Scientists scan brains of people with autism and Fragile-X to spot key differences
NCT ID NCT02719951
First seen Jan 10, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study used a special brain scan (PET imaging) to measure how a chemical called glutamate works in the brains of 27 men with autism, Fragile-X syndrome, or no condition. The goal was to better understand brain activity differences, not to test a treatment. Participants were all men aged 18 to 45.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Tours
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.